Skip to main content

Table 2 Three-year overall and relapse-free survival rates, and one-year survival after relapse rates in MSS/left and MSS/right populations, stratified by mutation status

From: Context-dependent interpretation of the prognostic value of BRAF and KRAS mutations in colorectal cancer

 

MSS/left

MSS/right

Population

Survival rate

95% CI

Survival rate

95% CI

OS: 3-year survival rates

WT2

0.91

0.88-0.93

0.83

0.77-0.89

KRAS mut

0.89

0.85-0.93

0.80

0.74-0.86

BRAF mut

0.37

0.20-0.66

0.73

0.60-0.89

RFS: 3-year survival rates

WT2

0.75

0.71-0.80

0.75

0.68-0.82

KRAS mut

0.68

0.62-0.74

0.73

0.66-0.80

BRAF mut

0.32

0.16-0.61

0.68

0.54-0.84

SAR: 1-year survival rates

WT2

0.81

0.74-0.88

0.65

0.52-0.82

KRAS mut

0.80

0.71-0.89

0.75

0.53-0.80

BRAF mut

0.17

0.05-0.60

0.36

0.17-0.79

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us